Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Solventum Corporation Common Stock (NY:SOLV)

74.67 +0.94 (+1.28%)
Streaming Delayed Price Updated: 11:38 AM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Solventum Corporation Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
3 Profitable Stocks Walking a Fine Line
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
Topics Intellectual Property
News headline image
3 Value Stocks We Keep Off Our Radar
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful... 
Via StockStory
News headline image
The Great Unbundling: 2026 Marks the Rise of the ‘Breakup’ Activist
As the first month of 2026 draws to a close, the U.S. financial landscape is being reshaped by an aggressive, new era of shareholder activism. No longer content with minor board adjustments or modest... 
Via MarketMinute
Topics ETFs Economy
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Industrial Resilience: 3M Exceeds 2025 Targets as CEO Bill Brown Plots Growth for 2026
The morning of January 20, 2026, 3M (NYSE: MMM) released its fourth-quarter and full-year 2025 financial results, signaling a definitive turn in the company’s multi-year effort to shed its image as a... 
Via MarketMinute
Topics Artificial Intelligence Economy Lawsuit
News headline image
The Great Industrial Turnaround: A Deep Dive into the New 3M (MMM) in 2026
Date: January 19, 2026 Author: Finterra Research Team Introduction As the opening bell prepares to ring on a new week, all eyes in the industrial sector are fixed on St. Paul. 3M Company (NYSE: MMM),... 
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
Surgical Equipment & Consumables - Diversified Stocks Q3 Earnings: STERIS (NYSE:STE) Best of the Bunch
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including STERIS... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Solventum (SOLV): The 3M Spin-Off That Found Its Rhythm – A 2026 Deep-Dive Analysis
Date: January 14, 2026 Introduction Since its high-profile separation from industrial conglomerate 3M Company (NYSE: MMM) in April 2024, Solventum Corporation (NYSE: SOLV) has undergone a profound... 
Via Finterra
Topics Artificial Intelligence World Trade
News headline image
3 Reasons SOLV is Risky and 1 Stock to Buy Instead
Solventum trades at $79.45 per share and has stayed right on track with the overall market, gaining 7.3% over the last six months. At the same time, the S&P 500 has returned 11.3%. 
Via StockStory
Topics Stocks
These S&P500 stocks are moving in today's session ↗
Via Chartmill
Stay informed with the top movers within the S&P500 index on Tuesday. ↗
Via Chartmill
News headline image
BTIG's Top Stock Picks for H1 2026: Navigating the New 'Application' Era
As the financial markets open for the 2026 calendar year, BTIG has released its highly anticipated "Top Picks" report for the first half of the year, signaling a transition from the speculative fervor... 
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
1 Mid-Cap Stock on Our Buy List and 2 We Question
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
News headline image
These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them? ↗
After tepid performances throughout most of 2025, these stocks are showing some upward momentum. 
Via The Motley Fool
Topics Stocks
News headline image
1 Unpopular Stock That Should Get More Attention and 2 We Ignore
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can... 
Via StockStory
News headline image
Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity ↗
Via MarketBeat
News headline image
Teleflex, Solventum, Haemonetics, Centene, and Molina Healthcare Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy
News headline image
Tech Stocks Fall Despite Nvidia's Beat, Walmart Jumps 6%: What's Moving Markets Thursday? ↗
Nvidia Corp. (NASDAQ:NVDA) delivered another blockbuster quarter and raised its outlook, but even that wasn't enough to lift Wall Street on Thursday. 
Via Benzinga
News headline image
What's going on in today's session: S&P500 movers ↗
Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Unpacking Q3 Earnings: Solventum (NYSE:SOLV) In The Context Of Other Surgical Equipment & Consumables - Diversified Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at surgical equipment & consumables -... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
1 Healthcare Stock to Own for Decades and 2 We Avoid
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
News headline image
5 Must-Read Analyst Questions From Solventum’s Q3 Earnings Call
Solventum’s third quarter results met Wall Street’s revenue expectations and exceeded consensus for non-GAAP earnings, with organic growth led by volume improvements across key segments. Management... 
Via StockStory
Topics Earnings Economy World Trade
News headline image
Get insights into the top movers in the S&P500 index of Monday's pre-market session. ↗
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses. 
Via Chartmill
News headline image
What's going on in today's session: S&P500 movers ↗
Curious about the S&P500 stocks that are in motion on Friday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Friday's session: top gainers and losers in the S&P500 index ↗
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday. 
Via Chartmill
News headline image
Solventum (SOLV) Q3 2025 Earnings Call Transcript ↗
Solventum (SOLV) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Economy
News headline image
SOLV Q3 Deep Dive: Transformation Initiatives Drive Margin Gains Amid Tariff Headwinds
Healthcare solutions provider Solventum (NYSE:SOLV) reported Q3 CY2025 results exceeding the market’s revenue expectations, but sales were flat year on year at $2.10 billion. Its non-GAAP profit of... 
Via StockStory
Topics Economy World Trade
News headline image
Solventum Corp (NYSE:SOLV) Tops Q3 Earnings and Revenue Estimates ↗
Solventum (SOLV) Q3 earnings beat estimates with EPS of $1.50 and revenue of $2.10B. Despite the beat, sales were flat year-over-year. 
Via Chartmill
Topics Earnings
News headline image
Solventum’s (NYSE:SOLV) Q3: Beats On Revenue
Healthcare solutions provider Solventum (NYSE:SOLV) reported Q3 CY2025 results topping the market’s revenue expectations, but sales were flat year on year at $2.10 billion. Its non-GAAP profit of $1.50... 
Via StockStory
News headline image
Examining the Future: Solventum's Earnings Outlook ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.